DOCSLIB.ORG

Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients with Atrial Fibrillation a Nationwide Cohort Study

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients with Atrial Fibrillation a Nationwide Cohort Study [ Original Research Cardiovascular Disease ] Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation A Nationwide Cohort Study Peter Brønnum Nielsen , PhD ; Torben Bjerregaard Larsen , MD , PhD ; Anders Gorst-Rasmussen , PhD ; Flemming Skjøth , PhD ; Lars Hvilsted Rasmussen , MD , PhD ; and Gregory Y. H. Lip , MD BACKGROUND: The risk of ischemic stroke/thromboembolic events after an intracranial hemorrhage (ICH) in patients with atrial fi brillation (AF) who are on warfarin treatment is poorly characterized. Th e aim of this study was to assess the association between the risk of ischemic stroke/thromboembolic events and ICH. METHODS: Linkage of three Danish nationwide administrative registries in the period between 1999 and 2012 identified patients with AF on warfarin treatment. Event-rate ratios of stroke/thromboembolic events, major bleeding, and all-cause mortality stratifi ed by ICH were calculated, and Cox proportional hazard models were used to compare event rates among ICH survivors. A matched OR was calculated for ICH occurrences within 0 to 3 months relative to the 3 to 6 months prior to a stroke/thromboembolic event. A rate ratio of claimed warfarin prescriptions in a 3-month period pre- and post-ICH was also calculated. RESULTS: We studied 58,815 patients with AF (median age, 72.6 years; 60% men). When compared with the non-ICH group, the ICH group was at increased risk for stroke/systemic embolism/transient ischemic attack (TIA) (rate ratio, 3.67; 95% CI, 3.12-4.31) and mortality (rate ratio, 5.55; 95% CI, 5.20-5.92), but not for major bleeding (rate ratio, 1.06; 95% CI, 0.81-1.39). Th e matched OR of ICH occurrences prior to a stroke/systemic embolism/TIA was 4.33 (95% CI, 2.44-8.15). Th e rate ratio of claimed warfarin prescriptions post- and pre-ICH event was 0.28 (95% CI, 0.24-0.33). CONCLUSIONS: In this large-scale study of patients with AF treated with warfarin, fi rst-time ICH was associated with an increased rate of ischemic stroke/systemic embolism/TIA and mortality compared with the non-ICH group. Th ere was a decrease in the warfarin-prescription purchase rate in the post-ICH period compared with pre-ICH, which may partly explain the excess risk. CHEST 2015; 147(6):1651 - 1658 Manuscript received August 25, 2014; revision accepted October 31, Skjøth, and Rasmussen and Prof Lip), Department of Clinical Medicine, 2014; originally published Online First November 20, 2014. Faculty of Health, Aalborg University, Aalborg, Denmark; and University of Birmingham Centre for Cardiovascular Sciences (Prof Lip), City ABBREVIATIONS: AF 5 atrial fi brillation; CHA 2 DS2 -VASc 5 cardiac fail- ure or dysfunction, hypertension, age Ն 75 years (doubled), diabetes, Hospital, Birmingham, England . stroke (doubled)-vascular disease, age 65 to 74 years, and sex category FUNDING/SUPPORT : Th e Obel Family Foundation supported this study. (female); ICD-10 5 International Classifi cation of Diseases, 10th Revision ; CORRESPONDENCE TO: Gregory Y. H. Lip, MD, University of ICH 5 intracranial hemorrhage; INR 5 international normalized ratio; Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley NOAC 5 non-vitamin K oral anticoagulant; OAC 5 oral anticoagulant; Rd, Birmingham, B18 7QH, England; e-mail: [email protected] 5 5 TIA transient ischemic attack; VKA vitamin K antagonist © 2015 AMERICAN COLLEGE OF CHEST PHYSICIANS. Reproduction of AFFILIATIONS : From the Department of Cardiology (Drs Nielsen, this article is prohibited without written permission from the American Larsen, Gorst-Rasmussen, Skjøth, and Rasmussen), Atrial Fibrillation College of Chest Physicians. See online for more details. Study Group, Aalborg University Hospital, Aalborg, Denmark; Aalborg DOI: 10.1378/chest.14-2099 Thrombosis Research Unit (Drs Nielsen, Larsen, Gorst-Rasmussen, journal.publications.chestnet.org 1651 Downloaded From: http://journal.publications.chestnet.org/ by Veronica Wilson on 10/08/2015 Patients with atrial fi brillation (AF) have an increased In clinical practice, an ICH event necessitates temporary risk for ischemic stroke, and stroke-prophylactic treatment cessation of OAC therapy, requiring the physician to with oral anticoagulants (OACs) is recommended if one balance the risk of an additional bleeding event with the stroke risk factor is present. 1 Treatment with antithrom- risk of a thromboembolic event in the absence of OAC botic agents such as the vitamin K antagonists (VKAs) treatment.11 Th e preferred timing of OAC therapy resump- (eg, warfarin) reduces stroke by 64% and all-cause mor- tion aft er an ICH event has been much debated,12,13 tality by 26%, when compared with placebo or a control. 2 and suggestions diff er from 7 to 14 days to 30 weeks. 14-16 However, patients on warfarin therapy are also at a In practice, however, the timing of OAC therapy resump- higher risk of bleeding, the most severe being spontaneous tion is diffi cult, and attempts to err on the side of intracranial hemorrhage (ICH). Indeed, anticoagulation- caution may lead to general undertreatment (or non- associated intracerebral hemorrhage has been reported treatment), resulting in an increased risk for further to account for 20% of all ICH events. 3 fatal and disabling stroke among survivors of ICH. Th e anxiety of causing serious bleeding (particularly ICH) Th e objective of this study was to investigate outcomes can lead physicians to withhold anticoagulants in some of ischemic stroke and thromboembolic events associ- patients with AF, despite a greater benefi t from OAC ated with ICH among patients with AF. We hypothe- treatment (compared with no OAC or aspirin treatment) sized that patients experiencing an ICH event would be in terms of reduced risk of stroke. 4-6 More recently, the at increased risk for thromboembolism, as refl ected by a non-VKA OACs (NOACs, previously referred to as new composite of ischemic stroke, systemic embolism, and or novel OACs 7 ) have been shown to be associated with transient ischemic attack (TIA), and by all-cause mor- lower rates of ICH compared with VKAs, improving tality. Further, we hypothesized that this increase in safety, in addition to their effi cacy and convenience. 8-10 risk for thromboembolism among survivors of ICH Nonetheless, a history of ICH was an exclusion criterion would be accompanied by a decreased rate of warfarin- for patients included in recent trials of NOACs compared prescription purchase. We investigated these hypotheses with VKAs. in a large, nationwide cohort study. Materials and Methods was the composite of ischemic stroke/systemic embolism/TIA (ICD-10 diagnosis codes I63, I64, I74, G45). Secondary analyses were done on Registry Data Sources and Study Population major bleeding, as well as all-cause mortality. Th e defi nition of major All Danish residents are given a unique and permanent registration bleeding included acute posthemorrhagic anemia, hemothorax, con- number at the time of birth or immigration. Nationwide registries enable junctival hemorrhage, retinal hemorrhage, vitreous hemorrhage, recur- retrieval of individual patient data on (1) discharge diagnosis classifi ed rent and persistent hematuria, menopausal and other perimenopausal by the International Classifi cation of Diseases, 10th Revision (ICD-10) disorders, hemorrhage from the respiratory passages, unspecified and admission and discharge dates (the Danish National Patient hematuria, and unclassifi ed hemorrhage (ICD-10 diagnosis codes D62, Registry); (2) dispensed prescriptions identified by the Anatomic J942, H113, H356, H431, N02, N95, R04, R31, R58). 20 Therapeutic Chemical classification code, date of purchase, package size and volume of the medication since 1994 (the Danish National We imposed a dynamic stratifi cation on the cohort by considering each Prescription Registry); and (3) information on sex, date of birth, emi- patient’s ICH status during follow-up. At the index date, all patients gration, and vital status (the Danish Civil Registration System). were ICH free. If a patient sustained an ICH, they would move irrevers- ibly to the ICH group. Survivors of ICH were defi ned on the basis of the By linking the three databases, 17-19 we established a cohort of patients vital status from the Danish Civil Registration System (ie, no change in with incident nonvalvular AF. Nonvalvular AF was defi ned as presence the vital status at the day of an ICH diagnosis). of ICD-10 diagnosis code I48, and baseline absence of mitral stenosis and mechanical heart valve (ICD-10 diagnosis codes: I05 and Z952-Z954). The cardiovascular comorbidity and risk for stroke at baseline were Specifi cally, we identifi ed all patients discharged with a fi rst-time hos- assessed by the CHA 2 DS2 -VASc (cardiac failure or dysfunction, hyper- pital diagnosis (index date) of nonvalvular AF in the period January 1, tension, age Ն 75 years [doubled], diabetes, stroke [doubled]-vascular 1999, to December 31, 2012. e-Appendix 1 gives detailed defi nitions disease, age 65-74 years, and sex category [female]) score, with higher 21 on outcomes and concomitant pharmacotherapy. We excluded patients scores indicating greater risk for stroke. Th e CHA2 DS2 -VASc score has who died or experienced an ICH event (ICD-10 diagnosis codes: previously been applied in similar nationwide cohorts and is the pre- I60-I62, S063C, S064-S066, I690-I692) within the fi rst 7 days aft er the ferred risk stratifi cation tool for patients with AF, as recommended by index date. Patients who had claimed a prescription of heparin or the European Society of Cardiology. 22-25 We also calculated a (modifi ed) low-molecular-weight heparin or non-VKAs 1 year prior to the index HAS-BLED score (hypertension, abnormal renal and/or liver function, date were also excluded. We further restricted the cohort to patients stroke, bleeding history or predisposition, labile international normal- who initiated warfarin treatment, defi ned as a warfarin prescription ized ratio, elderly [ .
Load more

Recommended publications
  • Management of the Head Injury Patient
    Management of the Head Injury Patient William Schecter, MD Epidemilogy • 1.6 million head injury patients in the U.S. annually • 250,000 head injury hospital admissions annually • 60,000 deaths • 70-90,000 permanent disability • Estimated cost: $100 billion per year Causes of Brain Injury • Motor Vehicle Accidents • Falls • Anoxic Encephalopathy • Penetrating Trauma • Air Embolus after blast injury • Ischemia • Intracerebral hemorrhage from Htn/aneurysm • Infection • tumor Brain Injury • Primary Brain Injury • Secondary Brain Injury Primary Brain Injury • Focal Brain Injury – Skull Fracture – Epidural Hematoma – Subdural Hematoma – Subarachnoid Hemorrhage – Intracerebral Hematorma – Cerebral Contusion • Diffuse Axonal Injury Fracture at the Base of the Skull Battle’s Sign • Periorbital Hematoma • Battle’s Sign • CSF Rhinorhea • CSF Otorrhea • Hemotympanum • Possible cranial nerve palsy http://health.allrefer.com/pictures-images/ Fracture of maxillary sinus causing CSF Rhinorrhea battles-sign-behind-the-ear.html Skull Fractures Non-depressed vs Depressed Open vs Closed Linear vs Egg Shell Linear and Depressed Normal Depressed http://www.emedicine.com/med/topic2894.htm Temporal Bone Fracture http://www.vh.org/adult/provider/anatomy/ http://www.bartleby.com/107/illus510.html AnatomicVariants/Cardiovascular/Images0300/0386.html Epidural Hematoma http://www.chestjournal.org/cgi/content/full/122/2/699 http://www.bartleby.com/107/illus769.html Epidural Hematoma • Uncommon (<1% of all head injuries, 10% of post traumatic coma patients) • Located
    [Show full text]
  • Hypertensive Intracerebral Hemorrhage Due to Autonomic Dysreflexia in a Young Man with Cervical Cord Injury
    J UOEH（産業医科大学雑誌）35（ 2 ）: 159－164（2013） 159 ［Case Report］ Hypertensive Intracerebral Hemorrhage Due to Autonomic Dysreflexia in a Young Man with Cervical Cord Injury Tadashi Sumiya Department of Spinal Care Center, Division of Rehabilitation Medicine 219 Myoji, Katsuragi-cho, Ito-gun, 649-7113, Japan Abstract : The author reports the case of a 36 year old man with cervical cord injury in whom autonomic dysreflexia developed into intracerebral hemorrhage during inpatient rehabilitation. This patient showed complete quadriplegia (motor below C6 and sensory below C7) due to fracture of the 6th cervical vertebra. An indwelling urethral catheter had been inserted into the bladder for 3 months, diminishing bladder expansiveness. Bladder capacity decreased to 200 ml and the patient frequently experienced headaches whenever his bladder was full. To obtain smoother urine flow, a supra-pubic cystostomy was performed. The headaches were temporarily cured, but soon relapsed with extreme increases in blood pressure, representing typical symptoms of autonomic dysreflexia. However, no poten- tial triggers were identified or removed, and lack of blood pressure management led to left putaminal hemorrhage. Despite operative treatment, the right upper extremity showed progressive increases in muscle tonus and finally formed a frozen shoulder with elbow flexion contracture. Two factors contributed to this serious complication: first, autonomic dysreflexia triggered by minor malfunction and/or irritation from the cystostomy catheter; and second, the medical staff lacked sufficient experience in and knowledge about the management of autonomic dysreflexia. It is of the utmost importance for medical staff engaging in rehabilitation of spinal patients to share information regard- ing triggers of autonomic dysreflexia and to be thorough in ensuring proper medical management.
    [Show full text]
  • Intracerebral Hemorrhage ICH Fact Sheet
    FACT SHEET FOR PATIENTS AND FAMILIES Intracerebral Hemorrhage (ICH) What is it? An intracerebral [in-truh-suh-REE-bruh l] hemorrhage [HEM-rij], Dura mater or ICH, is bleeding inside or around the brain, which Brain Skull can put pressure on the brain. An ICH robs the brain Intracerebral of oxygen, so it must be identified and managed right hemorrhage away. Other names for ICH are cerebral hemorrhage or intracranial [in-truh-KREY-nee-uh l] hemorrhage. ICH can happen because of trauma or as a result of no known cause (spontaneous ICH), which is a type of stroke called a hemorrhagic [hem-oh-RAJ-ik] stroke. In the U.S. each year, about 1 in 10 people who have strokes do so because of an ICH. Stroke is the leading cause of disability and the 5th-leading cause of death in the U.S. What are the symptoms of spontaneous ICH? Spontaneous ICH symptoms usually develop suddenly, without warning. Key symptoms can include a SUDDEN (see BE FAST on page 2): What causes it? • Loss of balance or coordination An ICH is often caused by a blood vessel leaking or • Change in vision breaking. This can be the result of: • Weakness of the face, arm, or leg • High blood pressure that has damaged a blood vessel • Difficulty speaking • Smoking, overuse of alcohol, or use of illegal drugs Other ICH symptoms can include: such as cocaine or methamphetamine • Severe headache with no known cause (patients • Diabetes often describe it as “the worst headache of my life”) • Abnormal blood vessel proteins in the elderly • Seizures An ICH can also be caused by: • Vomiting or severe nausea, when combined with • Anticoagulant therapy (treatment with blood thinners) other symptoms from this list • Problems with vein structure • Partial or total loss of conciousness • A brain tumor that bleeds • Head injuries caused by a fall or accident 1 How is it diagnosed? What can I expect afterward? Your doctor will explain what tests will be used to Your long-term outlook depends on the location and diagnose ICH, depending on your condition.
    [Show full text]
  • Intracranial Hemorrhage As Initial Presentation of Cerebral Venous Sinus Thrombosis
    Case Report Journal of Heart and Stroke Published: 31 Dec, 2019 Intracranial Hemorrhage as Initial Presentation of Cerebral Venous Sinus Thrombosis Joseph Y Chu1* and Marc Ossip2 1Department of Medicine, University of Toronto, Canada 2Department of Diagnostic Imaging, William Osler Health System, Canada Abstract Intracranial Hemorrhage (ICH) as initial presentation is an uncommon complication of Cerebral Venous-Sinus Thrombosis (CVT). Clinical and neuro-imaging studies of 4 cases of ICH due cerebral venous-sinus thrombosis seen at the William Osler Health System in Toronto will be presented. Discussion of the immediate and long-term management of these interesting cases will be reviewed with emphasis on the appropriate neuro-imaging studies. Literature review of Direct Oral Anticoagulants (DOAC) in the long-term management of these challenging cases will be discussed. Introduction The following are four cases of Cerebral Venous-Sinus Thrombosis (CVT) who present initially as Intracranial Hemorrhage (ICH). Clinical details, including immediate and long term management and neuro-imaging studies are presented. Results Case 1 A 43 years old R-handed house wife, South-Asian decent, who was admitted to hospital on 06- 10-2014 with sudden headache and right hemiparesis. Her past health shows no prior hypertension or stroke. She is not on any hormone replacement therapy, non-smoker and non-drinker. Married with 1 daughter. Examination shows BP=122/80, P=70 regular, GCS=15, with right homonymous hemianopsia, right hemiparesis: arm=leg 1/5, extensor R. Plantar response. She was started on IV Heparin after her unenhanced CT showed acute left parietal intracerebral hemorrhage and her MRV showed extensive sagittal sinus thrombosis extending into the left transverse OPEN ACCESS sinus (Figures 1,2).
    [Show full text]
  • Early Management of Retained Hemothorax in Blunt Head and Chest Trauma
    World J Surg https://doi.org/10.1007/s00268-017-4420-x ORIGINAL SCIENTIFIC REPORT Early Management of Retained Hemothorax in Blunt Head and Chest Trauma 1,2 1,8 1,7 1 Fong-Dee Huang • Wen-Bin Yeh • Sheng-Shih Chen • Yuan-Yuarn Liu • 1 1,3,6 4,5 I-Yin Lu • Yi-Pin Chou • Tzu-Chin Wu Ó The Author(s) 2018. This article is an open access publication Abstract Background Major blunt chest injury usually leads to the development of retained hemothorax and pneumothorax, and needs further intervention. However, since blunt chest injury may be combined with blunt head injury that typically requires patient observation for 3–4 days, other critical surgical interventions may be delayed. The purpose of this study is to analyze the outcomes of head injury patients who received early, versus delayed thoracic surgeries. Materials and methods From May 2005 to February 2012, 61 patients with major blunt injuries to the chest and head were prospectively enrolled. These patients had an intracranial hemorrhage without indications of craniotomy. All the patients received video-assisted thoracoscopic surgery (VATS) due to retained hemothorax or pneumothorax. Patients were divided into two groups according to the time from trauma to operation, this being within 4 days for Group 1 and more than 4 days for Group 2. The clinical outcomes included hospital length of stay (LOS), intensive care unit (ICU) LOS, infection rates, and the time period of ventilator use and chest tube intubation. Result All demographics, including age, gender, and trauma severity between the two groups showed no statistical differences.
    [Show full text]
  • Symptomatic Intracranial Hemorrhage (Sich) and Activase® (Alteplase) Treatment: Data from Pivotal Clinical Trials and Real-World Analyses
    Symptomatic intracranial hemorrhage (sICH) and Activase® (alteplase) treatment: Data from pivotal clinical trials and real-world analyses Indication Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symptom onset. Important Safety Information Contraindications Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3 months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding (e.g., some neoplasms, arteriovenous malformations, or aneurysms); bleeding diathesis; and current severe uncontrolled hypertension. Please see select Important Safety Information throughout and the attached full Prescribing Information. Data from parts 1 and 2 of the pivotal NINDS trial NINDS was a 2-part randomized trial of Activase® (alteplase) vs placebo for the treatment of acute ischemic stroke. Part 1 (n=291) assessed changes in neurological deficits 24 hours after the onset of stroke. Part 2 (n=333) assessed if treatment with Activase resulted in clinical benefit at 3 months, defined as minimal or no disability using 4 stroke assessments.1 In part 1, median baseline NIHSS score was 14 (min: 1; max: 37) for Activase- and 14 (min: 1; max: 32) for placebo-treated patients. In part 2, median baseline NIHSS score was 14 (min: 2; max: 37) for Activase- and 15 (min: 2; max: 33) for placebo-treated patients.
    [Show full text]
  • Of These, About 62% Are Women. STROKE: an OVERV
    STROKE: AN OVERVIEW It is estimated that more than 700,000 Americans suffer a cerebrovascular event, or stroke, each year. Approximately 500,000 of these are first strokes, and 200,000 are recurrent attacks. On average, someone suffers a stroke every 45 seconds, and a stroke death occurs every 3.1 minutes (1). According to American Heart Association data, approximately 4,700,000 stroke survivors are alive in the United States today (2). Stroke is the leading In West Virginia, between 1,200 and cause of adult disability in the United States and the 1,300 people die from stroke each year; third leading cause of death nationwide. In West of these, about 62% are women. Virginia, stroke ranks as the fourth leading cause of death, after heart disease, cancer, and chronic lower respiratory disease; between 1,200 and 1,300 people die from stroke each year in the state. Death rates from stroke declined markedly in the 1970s and 1980s in both the state and the country as a whole; however, this decline leveled off in the 1990s (3). Figure 1 illustrates the latter part of this trend, showing 20 years of stroke mortality rates in West Virginia among men and women. Rates among both men and women decreased in the state rather consistently until 1992, after which slight increases occurred. -1- Even though the mortality rate for stroke declined 12.3% from 1990 to 2000 in the United States, the actual number of stroke deaths rose nearly 10% (2) and stroke-related hospitalizations increased 19% (4). National projections for stroke mortality are bleak.
    [Show full text]
  • Canadian Stroke Best Practice Recommendations
    CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS MANAGEMENT OF SPONTANEOUS INTRACEREBRAL HEMORRHAGE Seventh Edition - New Module 2020 Ashkan Shoamanesh (Co-chair), M. Patrice Lindsay, Lana A Castellucci, Anne Cayley, Mark Crowther, Kerstin de Wit, Shane W English, Sharon Hoosein, Thien Huynh, Michael Kelly, Cian J O’Kelly, Jeanne Teitelbaum, Samuel Yip, Dar Dowlatshahi, Eric E Smith, Norine Foley, Aleksandra Pikula, Anita Mountain, Gord Gubitz and Laura C. Gioia(Co-chair), on behalf of the Canadian Stroke Best Practices Advisory Committee in collaboration with the Canadian Stroke Consortium and the Canadian Hemorrhagic Stroke Trials Initiative Network (CoHESIVE). © 2020 Heart & Stroke October 2020 Heart and Stroke Foundation Management of Spontaneous Intracerebral Hemorrhage Canadian Stroke Best Practice Recommendations Table of Contents CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS MANAGEMENT OF SPONTANEOUS INTRACERBRAL HEMORRHAGE SEVENTH EDITION, 2020 Table of Contents Topic Page Part One: Canadian Stroke Best Practice Recommendations Introduction and Overview I. Introduction 3 II. Spontaneous Intracerebral Hemorrhage Module Overview 3 III. Spontaneous Intracerebral Hemorrhage Definitions 4 IV. Guideline Development Methodology 4 V. Acknowledgements, Funding, Citation 6 VI. Figure One: Intracerebral Hemorrhage Patient Flow Map 8 Part Two: Canadian Stroke Best Practice Recommendations Spontaneous Intracerebral Hemorrhage 1. Emergency Management of Intracerebral Hemorrhage 9 1.1 Initial Clinical Assessment of Intracerebral Hemorrhage 9 1.2 Blood Pressure Management 10 1.3 Management of Anticoagulation 11 1.4 Consultation with Neurosurgery 12 1.5 Neuroimaging 12 1.5.1 Recommended additional urgent neuroimaging to confirm ICH diagnosis 12 1.5.2 Recommended additional etiological neuroimaging 13 1.6 Surgical management of Intracerebral Hemorrhage 13 Box One: Symptoms of Intracerebral Hemorrhage: 15 Box Two: Modified Boston Criteria (Linn 2010) 16 2.
    [Show full text]
  • Your Health Matters Intracerebral Hemorrhage (ICH)
    Your Health Matters Intracerebral Hemorrhage (ICH) Overview Intracerebral hemorrhage happens when a diseased blood vessel inside the brain bursts, letting the blood leak inside the brain. (The name means within the cerebrum or brain). This problem is also called a hemorrhagic stroke. The sudden increase in pressure inside the brain can cause damage to the brain cells exposed to the blood. If the amount of blood increases too fast, the sudden buildup in pressure can lead to unconsciousness or death. Intracerebral hemorrhage usually happens in selected parts of the brain, including the basal ganglia, cerebellum, brain stem, or cortex. *The most common cause of intracerebral hemorrhage is high blood pressure. Since high blood pressure by itself often causes no symptoms, many people with intracranial hemorrhage are not aware that they have high blood pressure, or that it needs to be treated. Less common causes of intracerebral hemorrhage include trauma, infections, tumors, blood clotting deficiencies, drug abuse and abnormalities in blood vessels (such as an aneurysm or arteriovenous malformations AKA “AVM”). Symptoms **Symptoms usually come on suddenly and can change depending on the location of the bleed. They may sometimes develop in a stepwise pattern, or they may get worse over time. Common symptoms include: • Sudden weakness or numbness of face, arm or leg; especially if the numbness is all on one side of the body • Sudden confusion, trouble speaking or understanding • Sudden trouble seeing in one or both eyes • Sudden trouble walking,PROOF
    [Show full text]
  • Migraine with Vasospasm and Delayed Intracerebral Hemorrhage
    Migraine With Vasospasm and Delayed Intracerebral Hemorrhage Andrew J. Cole, MD, Michel Aub\l=e'\,MD \s=b\Three women with well-documented brain-stem lesions have each been de¬ difficult to arouse, and was again brought to migraine associated with intracerebral scribed. In the majority, neurological the emergency department. She was hyper- hemorrhage are described. In each case, dysfunction is attributed to ischemie tesive, bradycardic, and stuporous, but, af¬ ter was able to follow migraine headaches began during adult- stroke, presumably secondary to vas¬ stimulation, simple commands. She had a dense left hemiplegia hood. Unusually severe and protracted cular spasm. Intracerebral hemor¬ associated with a left-sided homonymous headache heralded the onset of fixed neu- in has rhage migrainous patients only hemianopia and right gaze preference. rological deficits associated with lobar in- rarely been reported,7 and has some¬ Brain computed tomographic scanning tracerebral carotid hemorrhage. Striking times been associated with preexisting demonstrated a right frontoparietal intra¬ artery tenderness was characteristic. Ex- arteriovenous malformations.8·9 This cerebral hemorrhage (Fig 1, center). A ca¬ cept for a history of migraine, no cause for article describes a group of patients, rotid arteriogram showed narrowing of the intracerebral hemorrhage could be estab- all of whom are female, affected with Ml segment of the right middle cerebral lished. In each case arteriography showed migraine who presented with lobar in¬ artery (Fig 1, right). There was mass effect related to the but no evidence of extensive spasm of the appropriate ex- tracerebral hemorrhage either during hematoma, arteriovenous or tracranial or intracranial artery. Surgical or mi¬ malformation, aneurysm, immediately following typical tumor.
    [Show full text]
  • Read Onlinepdf 18.98 MB
    ResidentOfficial Publication of the Emergency Medicine Residents’ Association December 2018/January 2019 VOL 45 / ISSUE 6 Exertional Rhabdomyolysis EmBassador Travel Team Seeking the Best and Brightest EM Physicians Enjoy the flexibility to live where you want and practice where you are needed. EmBassador TRAVEL TEAM PHYSICIANS RECEIVE: Paid travel and Practice variety accommodations Concierge support Travel convenience package Regional engagements, Paid medical staff dues, equitable scheduling and licenses, certifications and no mandatory long-term applications employment commitment Exceptional Fast track to future compensation package leadership opportunities For More Information: Mansoor Khan, MD National Director, EmBassador Program 917.656.6958 | [email protected] ENVISION PHYSICIAN SERVICES OFFERS ... programs that align physicians to become leaders MANSOOR KHAN, MD, MHA, FAAEM EMERGENCY MEDICINE Why EM Residents choose Envision Physician Services ■ Professional Development and Career Advancement ■ Employment Flexibility: Full-Time, Part-Time, moonlighting and travel team. Employed and Independent Contractor options ■ Practice Variety: Coast-to-coast opportunities at well-recognized hospitals and health systems ■ Unparalleled practice support ■ Earn While You Learn Program: Provides senior residents with $2,500/month while you complete your residency For more information, contact: 877.226.6059 [email protected] TABLE OF CONTENTS EDITORIAL STAFF Categories EDITOR-IN-CHIEF Tommy Eales, DO Indiana University COVER STORY DEPUTY
    [Show full text]
  • Endovascular Management of Acute Epidural Hematomas: Clinical Experience with 80 Cases
    CLINICAL ARTICLE J Neurosurg 128:1044–1050, 2018 Endovascular management of acute epidural hematomas: clinical experience with 80 cases Carlos Michel A. Peres, MD,1 Jose Guilherme M. P. Caldas, MD, PhD,2 Paulo Puglia Jr., MD,2 Almir F. de Andrade, MD, PhD,3 Igor A. F. da Silva, MD,3 Manoel J. Teixeira, MD, PhD,3 and Eberval G. Figueiredo, MD, PhD3 1Hospital Universitário Francisca Mendes, Manaus; and Divisions of 2Neuroradiology and 3Neurosurgery, University of São Paulo School of Medicine, São Paulo, Brazil OBJECTIVE Small acute epidural hematomas (EDHs) treated conservatively carry a nonmeasurable risk of late en- largement due to middle meningeal artery (MMA) lesions. Patients with EDHs need to stay hospitalized for several days, with neurological supervision and repeated CT scans. In this study, the authors analyzed the safety and efficacy of the embolization of the involved MMA and associated lesions. METHODS The study group consisted of 80 consecutive patients harboring small- to medium-sized EDHs treated by MMA embolization between January 2010 and December 2014. A literature review cohort was used as a control group. RESULTS The causes of head injury were falls, traffic-related accidents (including car, motorcycle, and pedestrian vs vehicle accidents), and assaults. The EDH topography was mainly temporal (lateral or pole). Active contrast leaking from the MMA was seen in 57.5%; arteriovenous fistulas between the MMA and diploic veins were seen in 10%; and MMA pseudoaneurysms were found in 13.6% of the cases. Embolizations were performed under local anesthesia in 80% of the cases, with N-butyl-2-cyanoacrylate, polyvinyl alcohol particles, or gelatin sponge (or a combination of these), obtaining MMA occlusion and complete resolution of the vascular lesions.
    [Show full text]